APD-588 inhibits inflammation and airway hyperresponsiveness in model of allergic asthma May 21, 2019 No Comments
resTORbio initiates phase III program of RTB-101 in clinically symptomatic respiratory illness May 10, 2019 No Comments
Verona initiates phase IIb study of nebulized ensifentrine in moderate to severe COPD May 7, 2019 No Comments
Phase III study of Trelegy Ellipta in uncontrolled asthma meets primary endpoint May 3, 2019 No Comments
Maruishi reports results from Japanese phase III study of Traumakine in ARDS April 29, 2019 No Comments
RSS